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Fragile X syndrome is the most common inherited form of cognitive deficiency in humans and perhaps the
best-understood single cause of autism. A trinucleotide repeat expansion, inactivating the X-linked FMR1
gene, leads to the absence of the fragile X mental retardation protein. FMRP is a selective RNA-binding pro-
tein that regulates the local translation of a subset of mRNAs at synapses in response to activation of Gp1
metabotropic glutamate receptors (mGluRs) and possibly other receptors. In the absence of FMRP, excess
and dysregulated mRNA translation leads to altered synaptic function and loss of protein synthesis-depen-
dent plasticity. Recent evidence indicates the role of FMRP in regulated mRNA transport in dendrites. New
studies also suggest a possible local function of FMRP in axons that may be important for guidance, synaptic
development, and formation of neural circuits. The understanding of FMRP function at synapses has led to
rationale therapeutic approaches.Introduction
Geneticists first choose an interesting phenotype, then search
for the responsible mutation and hope subsequent studies pro-
vide mechanistic insight into biology. Fragile X syndrome (FXS)
and the FMR1 gene have proved how effective this paradigm
can be. FXS is the most frequent form of inherited mental retar-
dation and often presents as an autism spectrum disorder
(Garber et al., 2008). This X-linked disorder was notable for its
unusual inheritance pattern, referred to as the Sherman paradox.
Sherman had shown in the 1980s the occurrence of nonpene-
trant male carriers in fragile X syndrome families, an unusual ob-
servation for an X-linked disorder, and that these males could
transmit their alleles to nonpenetrant daughters who could
then have affected sons (Sherman et al., 1985). Moreover, a car-
rier female’s risk of having an affected son was related to her
pedigree position relative to such nonpenetrant males, in es-
sence showing increased penetrance of the fragile X mutation
as the mutant gene passed to subsequent generations. Another
feature stimulating interest was the poorly understood phenom-
enon of a ‘‘fragile site’’ or unstaining gap on the metaphase X
chromosome among affected individuals that segregated with
themutant gene (Penagarikano et al., 2007). In 1991, the respon-
sible gene was identified by positional cloning and named the
Fragile X Mental Retardation 1 gene (Verkerk et al., 1991). The
FMR1 gene resides precisely at the cytogenetic fragile X site
and was the first example of a trinucleotide repeat mutation.
Within the 50-untranslated region of FMR1 is a polymorphic
CGG repeat with the most common normal length of 30 triplets
(Figure 1). Among individuals with FXS, this repeat is found to
be expanded beyond 200 repeats, typically 800 repeats, and
is referred to as the full mutation. Alleles with an intermediate re-
peat length (55–200 repeats) are called premutations, typically
found in FXS families, accounting for the nonpenetrant males
observed by Sherman. Their daughters also are premutationcarriers. However, premutation alleles are unstable in meiosis,
particularly in female meiosis, often increasing in length from
one generation to the next, with the chance of expansion into
the full mutation range positively correlated with maternal pre-
mutation repeat length. Thus, the repeat length and instability
accounts for the Sherman paradox (Fu et al., 1991). Although
beyond the scope of this review, premutation alleles are them-
selves associated with phenotypes not found in FXS, such as
an adult-onset, primarily male, neurodegenerative disorder and
in female premutation carriers, primary ovarian insufficiency
(Hagerman and Hagerman, 2007). The mechanism of premuta-
tion disease is likely RNA mediated (Swanson and Orr, 2007).
In FXS, the full mutation allele is subjected to repeat-induced
silencing by a poorly understood mechanism, leaving this locus
heavily methylated with heterochromatic marks (Coffee et al.,
1999; Sutcliffe et al., 1992). Hence, the full mutation allele is si-
lenced, and the absence of the encoded protein, FMRP, results
in FXS. It should be noted that, since repeat expansion is be-
lieved to be the most prevalent mutation in FMR1, conventional
mutations of FMR1, such as nonsense and missense mutations,
are not routinely screened for clinically, despite the full mutation
being only one among many mutational mechanisms that give
rise to a null mutation. Thus, more attention on the conventional
mutations may lead to a broader phenotypic spectrum than is
currently recognized for FXS and give us a better understanding
of key FMRP residues.
The FMR Protein
The FMR1 gene codes for the fragile X mental retardation pro-
tein, FMRP, an mRNA-binding protein (Ashley et al., 1993) that
is expressed in many tissues and is abundant in the brain, where
it is believed to regulate a substantial mRNA population. Indeed,
FMRP is found to selectively bind4%of themRNA in themam-
malian brain. FMRP is predominantly a 71 kDa protein, althoughNeuron 60, October 23, 2008 ª2008 Elsevier Inc. 201
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ReviewFigure 1. FMR1 Protein and Gene
(Top) Protein domains (green) and key residues (red). NLS, nuclear localization signal; KH1 and KH2, RNA-binding domains; NES, nuclear export signal; RGG,
RGG box, RNA binding. I304N, naturally occurring FXS mutation abrogating polysome association; S499, primary phosphorylated serine. (Middle) FMR1 gene,
coding exons (blue) and untranslated regions (gray). Exons coding for major protein domains are indicated as well as alternative splicing. (Bottom) 50 untranslated
CGG-repeat alleles. The common and intermediate normal alleles (<55 repeats) are indicated, as are the premutation carrier alleles (55–200 repeats) and the full-
mutation FXS alleles (>200 repeats).several isoforms exist as a result of alternative splicing (Figure 1).
The physiological role of distinct isoforms remains understudied
and poorly understood. The protein is highly conserved (92%
identity between human and chicken) and in mammals is one
of three paralogous proteins (with the FXR1 and FXR2 proteins),
whereas inDrosophila there is but a single orthologous protein in
this small vertebrate gene family. FMRP contains several highly
conserved domains. Both nuclear localization and nuclear ex-
port signals are found in FMRP, consistent with the observation
that FMRP shuttles between the nucleocytoplasmic space
(Eberhart et al., 1996; Sittler et al., 1996); however, the role of
FMRP in the nucleus has received scant attention since these
early reports (Fridell et al., 1996). The best-characterized motifs
in FMRP are those that interact with RNA: two hnRNP-K-homol-
ogy (KH) domains and an arginine-glycine-glycine (RGG box).
Although precise details and function have yet to be eluci-
dated, a stem-G-quartet loop in RNA is recognized by the
RGG box in vitro (Schaeffer et al., 2001), and such G-quartet
structures are found on several FMRP-associated mRNAs
(Brown et al., 2001; Darnell et al., 2001). FMRP-ligand mRNAs
containingGquartets include those encodingMAP1b, amicrotu-
bule-associated protein important for axonal development;
SAPAP3/4, which are postsynaptic scaffolding proteins that
bind PSD-95; NAP-22, a calmodulin-binding protein associated
with lipid rafts; Munc13, a SNARE-associated protein involved in
neurotransmitter release; Rab6-interacting protein; and the axon
guidance factor, semaphorin 3F. Molecular interactions between
FMRP and Fmr1, MAP1b and Sema3FmRNAs involving G-quar-
tet/quadruplex structures have been validated using biophysical
methods (Menon et al., 2008; Menon and Mihailescu, 2007;202 Neuron 60, October 23, 2008 ª2008 Elsevier Inc.Schaeffer et al., 2001). The coimmunoprecipitation of FMRP
with MAP1bmRNA in mouse brain has been confirmed by differ-
ent laboratories (Lu et al., 2004; Zalfa et al., 2003) and is also ob-
served in Drosophila between dFMRP and futsch, the MAP1b
homolog (Zhang et al., 2001), suggesting that the interaction be-
tween FMRP and at least one target mRNA is evolutionarily con-
served. More recently, reversible crosslinking-IP (CLIP) showed
that FMRP binds directly to PSD-95 mRNA in situ (Zalfa et al.,
2007). FMRP binding to the 30 UTR of PSD-95 mRNA in vitro in-
volves the C terminus of FMRP, which contains the RGG box.
While the 30 UTR of PSD-95 mRNA does contain a putative
G quartet (Todd et al., 2003), FMRP binding to this structured
G-rich region was not disrupted by lithium (Zalfa et al., 2007),
which does disrupt G-quartet-dependent binding to FMRP
(Darnell et al., 2001). Recently, FMRP was also shown to interact
by co-IP with a guanine-rich, G-quartet-like sequence in amyloid
precursor protein (APP) mRNA (Westmark and Malter, 2007).
These studies indicate that FMRP can bind to structured
G-rich regions, including the canonical G quartet (Table 1).
Several biochemical studies have clearly shown that FMRP is
associated with actively translating polyribosomes in both cul-
tured neuronal and nonneuronal cells, as well as in brain synap-
toneurosomes (Feng et al., 1997b; Khandjian et al., 2004; Stefani
et al., 2004). The KH domains appear crucial for the interaction of
FMRP with polyribosomes. The importance of these domains
becomes obvious given the observation of a rare FXS patient
harboring a missense mutation in the second KH domain that in-
terferes with ribosome interaction (Feng et al., 1997a); this has
been recapitulated in a knockin mouse (Darnell et al., personal
communication). However, the role of the KH domains in binding
Neuron
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mRNA
Dendritic
Localization
G-Quartet-like
Structure
mGluR
Stimulated Method References
App + + Co-IP Westmark and Malter, 2007
Arc + + Co-IP Steward and Worley, 2001; Waung et al., 2008;
Park et al., 2008
CamKIIa + + Co-IP Bramham and Wells, 2007; Muddashetty et al., 2007;
Hou et al., 2006; Zalfa et al., 2003
eEF1A + + Co-IP; in vitro Huang et al., 2005; Sung et al., 2003
Fmr1 + + + in vitro Weiler et al., 1997; Antar et al., 2004; Schaeffer et al., 2001
GluR1/2 + + Co-IP Muddashetty et al., 2007
Map1b + + + Co-IP; in vitro;
biophysical
Brown et al., 2001; Darnell et al., 2001; Antar et al., 2005;
Davidkova and Carroll, 2007; Hou et al., 2006;
Menon et al., 2008
Psd95 + + + Co-IP; in vitro; CLIP Todd et al., 2003; Zalfa et al., 2007; Muddashetty et al., 2007
Sapap3/4 + + Co-IP Brown et al., 2001; Kindler et al., 2004; Narayanan et al., 2007;
Dictenberg et al., 2008
Sema3F + Co-IP; biophysical Darnell et al., 2001; Menon and Mihailescu, 2007
Rgs5 + + APRA; in vitro Miyashiro et al., 2003; Dictenberg et al., 2008
Gaba-Ad + + APRA; in vitro Miyashiro et al., 2003; Dictenberg et al., 2008
The criteria for inclusion on this short list are evidence for an FMRP association in vitro or in vivo, evidence for dendritic mRNA localization or synaptic
synthesis, and evidence for mGluR regulation. Sema3F does not meet these criteria and is included here as one example of an FMRP ligand that may
play an important role outside of the mGluR theory for FMRP function. (+) Indicates positive while no symbol reflects lack of direct examination or un-
clear results. Several methods have been used to assess FMRP-target mRNA interactions, i.e., co-IP, CLIP, APRA, and direct in vitro methods (filter
binding, gel-shift, affinity capture, UV crosslinking, biophysical). A number of targets contain a validated G-quartet structure or G-rich region that is
necessary for FMRP binding. G quartets are determined by various approaches in the literature and are therefore referred to as G-quartet-like struc-
tures. Those mRNAs indicated to be lacking a perfect G-quartet-like structure may still have approximations of DWGG-N(0-5)DWGG-N(0-3)-DWGG-
N(0-2)-DWGG, derived from Table 1 of Darnell et al. (2001). For example, the binding of FMRP to the PSD-95 30 UTR involved a structuredG-rich region,
within a predicted G quartet, although binding occurred in the presence of lithium (Zalfa et al., 2007). Note also that other modes of FMRP interaction
have been described, such as U-rich sequences (Dolzhanskaya et al., 2003) and kissing complex structures (Darnell et al., 2005). Several of the above
FMRP-target mRNAs have been shown to be regulated by mGluR stimulation, either at the level of mRNA transport, stability, translation, or protein
expression.specific mRNAs and the precise RNA targets of these domains
are unclear. Darnell et al. reported an in vitro selected RNA struc-
ture that binds tightly to the KH2 domain, the so-called kissing
complex (Darnell et al., 2005). This RNA could compete FMRP
off polyribosomes, something the G-quartet structure was un-
able to do. Nevertheless, despite considerable effort, there has
been no similar structure reported in any naturally occurring
RNA molecule. It is possible that the kissing complex approxi-
mates the structure of two distinct RNAmolecules interacting to-
gether with the KHdomain. One notion, based on the association
of FMRPmRNP complexes withmicroRNAs and protein compo-
nents of themicroRNA pathway, is that there is an interaction be-
tween specific microRNAs and target mRNAs, which together
could be recognized by the KH domain (Jin et al., 2004). Another
possibility is an interaction between mRNAs and the BC1 RNA,
which reportedly interacts with FMRP (Zalfa et al., 2003). How-
ever, recent studies failed to verify a specific interaction between
BC1 and FMRP, calling this interaction into question (Iacoangeli
et al., 2008a) and generating some controversy (Bagni, 2008; Ia-
coangeli et al., 2008b). This debate notwithstanding, the precise
function of the FMRP KH domains and the interaction of FMRP
with noncoding RNAs, including miRNAs, remain important ave-
nues of inquiry into the role of FMRP in translational regulation.Fragile X Phenotype Suggests FMRP Affects Dendritic
mRNA Function
A hallmark of the FXS neuroanatomical phenotype is the hyper-
abundance of dendritic spines with a long, thin, and otherwise
immature morphology (Grossman et al., 2006; Irwin et al.,
2000). An Fmr1 KO mouse model for FXS exhibits a similar ex-
cess of long, thin spines (Comery et al., 1997). Furthermore,
Fmr1 KO mice display altered learning and behavior, greater
susceptibility to seizures, and altered synaptic plasticity (Pena-
garikano et al., 2007). Since FMRP is associated with polyribo-
somes and localized to dendrites and spines (Antar et al.,
2004; Feng et al., 1997b), it is hypothesized to regulate the local
protein synthesis important for spine development and the syn-
aptic plasticity so critical for learning and memory (Antar and
Bassell, 2003; Bagni and Greenough, 2005; Grossman et al.,
2006). The synaptic phenotypes in FXS are believed to result
from impaired translational regulation. While the presence of
polyribosomes within spines have driven studies to find numer-
ous mRNAs that are selectively transported into dendrites and
translated at synapses (Bramham and Wells, 2007), the identity
of specific mRNA-binding proteins that play a direct role in
mRNA transport or translational regulation remained elusive until
recently (Kiebler and Bassell, 2006).Neuron 60, October 23, 2008 ª2008 Elsevier Inc. 203
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tion and local protein synthesis, at the time of the original micro-
array analysis of FMRP targets in the brain (Brown et al., 2001), it
was not knownwhether any of these were bona fide dendritically
localized mRNAs. Since that time, subsequent fluorescence
in situ hybridization (FISH) analysis demonstrated that FMRP co-
localized with MAP1b mRNA in dendrites of cultured neurons
(Antar et al., 2005). In addition, dendritic mRNA localization
was observed for SAPAP3 (Kindler et al., 2004), already appreci-
ated to be an FMRP ligand (Brown et al., 2001). Using an alterna-
tive microarray approach in cultured neurons to identify FMRP-
associated mRNAs, a few were shown to be localized to
dendrites, including the mRNA encoding regulator of G protein
signaling, RGS5 (Miyashiro et al., 2003). A candidate-based
approach revealed that the mRNAs encoding the a subunit of
calcium/calmodulin-dependent protein kinase II, a-CaMKII,
and the activity-regulated cytoskeletal-associated protein, Arc/
Ar3.1, were both coprecipitated with FMRP in brain extracts
(Zalfa et al., 2003). Since a-CaMKII and Arc/Arg3.1 are dendriti-
cally localized mRNAs that appear to be translated at synapses
(Bramham and Wells, 2007), this provides further evidence that
FMRP plays some role in dendritic mRNA regulation. More re-
cently, PSD-95 mRNA was shown to be dendritically localized
and directly associated with FMRP in vitro and in vivo (Mudda-
shetty et al., 2007; Zalfa et al., 2007). Taken together, these stud-
ies are consistent with the possibility that FMRP might bind and
regulate a subset of dendritic mRNAs.
While FMRP has been shown to associate with dendritic
mRNAs, it does not appear to be necessary for the constitutive
maintenance of their localization within dendrites. Analysis of
dendritic mRNA localization in vivo using in situ hybridization
failed to show any obvious differences in mRNA levels in den-
drites between WT and Fmr1 KO brain (Steward et al., 1998).
MAP2, a-CaMKII, and dendrin mRNAs, which are present con-
stitutively in dendrites, were indistinguishable between WT
and Fmr1 KO. Furthermore, the rapid transport of Arc/Arg3/1
mRNA into dendrites following seizures was not impaired in
Fmr1 KO brain. A more recent study found no gross reduction
in dendritic mRNA levels for a-CaMKII or PSD-95 in brain sec-
tions of cortex, hippocampus, or dentate gyrus (Muddashetty
et al., 2007). Notably, quantitative FISH analysis of a-CaMKII
and PSD-95 mRNA levels in dendrites of cultured neurons
showed no significant differences (Muddashetty et al., 2007).
However, one study reported that some APRA-identified FMRP
ligands (i.e., RGS5) did display modestly reduced mRNA levels
within dendrites of brain sections (Miyashiro et al., 2003). Com-
bined, these data indicate that FMRP does not play a role in
the steady-state maintenance or constitutive localization for
the majority of FMRP-associated mRNAs present in dendrites,
but this does not rule out the possibility that FMRPmay influence
the localization of a small subset of these. It is also possible that
observations of modest reduction in dendritic mRNA localization
may be due to reduced total mRNA levels, suggestive of a role for
FMRP in mRNA stability (Miyashiro et al., 2003), which could
modulate mRNA localization indirectly. With regard to PSD-95
mRNA, FMRP was found to modulate mRNA stability in hippo-
campal, but not cortical neurons (Zalfa et al., 2007). Total PSD-
95 mRNA levels were dramatically reduced in hippocampus,204 Neuron 60, October 23, 2008 ª2008 Elsevier Inc.but not cerebral cortex (Zalfa et al., 2007). In situ hybridization
signal for PSD-95mRNAwithin themolecular layer of hippocam-
pus was modestly reduced in Fmr1 KO, although this result was
not statistically significant (Zalfa et al., 2007). Nonetheless, re-
duced total levels of PSD-95 mRNA could explain the trend for
reduced dendritic localization. Of interest, PSD-95 30 UTR re-
porter mRNAs were less stable following transcriptional inhibi-
tion of FMRP-deficient hippocampal neurons. In contrast to the
results in hippocampus (Zalfa et al., 2007), both Zalfa et al.
(2007) and Muddashetty et al. (2007) reported that PSD-95
mRNA levels did not differ between wild-type and Fmr1 KO in
cortex. Thus, further work is needed to understand a possible
cell-type-specific role for FMRP in mRNA stability in hippocam-
pus. In that mechanisms of mRNA stability can be linked to local-
ization (Kiebler and Bassell, 2006), it will be interesting to assess
a possible dual role for FMRP. However, it is likely that other
mRNA-binding proteins are necessary for the steady state
and/or maintenance of mRNA levels within dendrites, whereas
FMRP may modulate localization, perhaps at the level of
mRNA stability. More dynamic assays in live neurons are needed
to rigorously assess a possible direct role for FMRP in the mech-
anism of dendritic mRNA transport (to be discussed in a later
section).
FMRP Regulation of Local Translation: Excess
and Dysregulated in Fragile X
FMRP can repress mRNA translation in vitro (Laggerbauer et al.,
2001; Li et al., 2001), and a general consequence of FMRP defi-
ciency in vivo is excess synthesis of specific proteins (Lu et al.,
2004; Muddashetty et al., 2007; Zalfa et al., 2003). Synaptoneur-
osomes (SNS) from Fmr1 KO mice have increased levels of
Map1b, a-CaMKII, and Arc protein, as well as higher levels of
these mRNAs in polyribosomal fractions, suggesting excess
translation at synapses (Zalfa et al., 2003). In a subsequent
study, the Fmr1 KO phenotype was characterized by the excess
translation of mRNAs at the basal state and loss of stimulus-
induced translation in cortical synaptoneurosomes (Mudda-
shetty et al., 2007). Quantitative real-time PCR analysis of
a-CaMKII, PSD-95, and GluR1/2 mRNA levels in polysome
gradient fractions from WT synaptoneurosomes showed that
these mRNAs are normally recruited into actively translating
polysomes in response to stimulation with DHPG, a Gp1 agonist
of mGluRs. However, in Fmr1 KO mice, this stimulus-induced
RNA shift is absent; rather, these mRNAs are elevated in polyri-
bosomes at the basal state, essentially mimicking the phenotype
observed in WT upon stimulation. Using metabolic labeling of
SNS with 35S-methionine, this study showed that the DHPG-
induced synthesis of PSD-95 and a-CaMKII protein was absent
in Fmr1 KO mice. There was no difference in mRNA abundance
in cortical synaptoneurosomes from WT and Fmr1 KO mice,
consistent with quantitative FISH analysis of mRNA levels in
the dendrites of cultured cortical neurons (Muddashetty et al.,
2007). These findings (Muddashetty et al., 2007) serve to recon-
cile past observations of translational excess at steady state
(Lu et al., 2004; Zalfa et al., 2003) with reports of deficient
mGluR-induced protein synthesis (Todd et al., 2003; Weiler
et al., 2004; Westmark and Malter, 2007) by showing that spe-
cific mRNAs have both characteristics in Fmr1 KOmice; namely,
Neuron
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Thus, although total mRNA levels in dendrites and at synapses
are not reduced in the absence of FMRP, these mRNAs are
translationally dysregulated.
The prevalent view in fragile X syndrome is that the synaptic
dysfunction and cognitive impairment are the result of excess
protein synthesis at the synapse (Ronesi andHuber, 2008).While
the excess translation is likely to be a major culprit, it may be of
equal concern that there is a loss of stimulus-induced transla-
tion. The inability of synapses in the FXS brain to control where
and when translation precisely occurs and the inability to aug-
ment translation in response to synaptic activity are likely to
have consequences on long-term plasticity, which influences
learning andmemory. Indeed, a loss of protein synthesis-depen-
dent plasticity has been observed, at least with regard to Gp1
mGluR LTD (Hou et al., 2006; Huber et al., 2002). Thus, the con-
cept of translational dysregulation at FMRP-deficient synapses
is likely to have important ramifications for the mechanism of
synaptic dysfunction and cognitive impairment in FXS.
FMRP Function in Synaptic Plasticity
and the mGluR Theory of FXS
A critical goal has been to investigate how FMRP-mediated
translational regulation is involved in long-term synaptic plastic-
ity. One form of synaptic plasticity with a now well-established
link to FMRP is a type of long-term depression (LTD) that de-
pends on activation of Gp1 metabotropic glutamate receptors
(mGluRs) (Ronesi and Huber, 2008). mGluR-dependent LTD,
which normally depends on the dendritic protein synthesis
needed for the persistent internalization of AMPAR, is enhanced
in Fmr1 KO mice and occurs independently of protein synthesis
(Huber et al., 2002; Nosyreva and Huber, 2006; Ronesi and
Huber, 2008). The mGluR theory of fragile X syndrome posits
that FMRP normally acts as a negative regulator of translation
downstream of Gp1 mGluRs, and in the absence of FMRP, there
is runaway protein synthesis that leads to excess AMPAR inter-
nalization and exaggerated LTD (Bear et al., 2004). In addition,
the mGluR theory suggests that many of the synaptic pheno-
types in FXS may be directly attributed to exaggerated mGluR
signaling, and therefore mGluR antagonists could be a useful
therapy for FXS. There is solid evidence to support this theory:
a number of phenotypes in animal models of FXS, including mor-
phologic, physiological, and behavioral impairments, have been
corrected either by administration of MPEP, an mGluR5 antago-
nist (McBride et al., 2005; Tucker et al., 2006; Yan et al., 2005), or
genetic reduction of mGluR5 (Dolen et al., 2007; Bassell and
Gross, 2008). FMRP-deficient neurons display excessive inter-
nalization of AMPAR at the basal state, but this defect can be
corrected by MPEP (Nakamoto et al., 2007). Exaggerated Gp1
mGluR signaling is the cause of prolonged epileptiform dis-
charges in hippocampal slices from Fmr1 KO (Chuang et al.,
2005). MPEP reduces the excess protein synthesis in hippocam-
pal slices from Fmr1 KO mice toward basal levels, suggesting
a direct correlation between the translational impairment and
FX phenotype (Dolen et al., 2007). In further support of this the-
ory, stimulation of Gp1 mGluRs can induce dendritic spine elon-
gation in vitro, reminiscent of the Fmr1 knockout mice (de Vrij
et al., 2008; Vanderklish and Edelman, 2002), and excess filopo-dial-spines present in Fmr1 KO neurons in vitro are corrected by
MPEP (de Vrij et al., 2008). Collectively, these data provide
strong support for the mGluR theory. It will be interesting to as-
sess the mechanism whereby specific translational responses
may be normalized by MPEP treatment. One implication is that
the excess protein synthesis has been lessened (Dolen et al.,
2007). However, it is also possible that reduction of basal trans-
lation, using MPEP, has enabled stimulus-induced translation to
now occur, either through Gp1 mGluRs (i.e., mGluR1) or other
receptors. As discussed above, the loss of protein synthesis-
dependent plasticity is a key feature of the synaptic impairment
in fragile X syndrome and may represent the primary reason
for cognitive impairment. Thus, for a therapeutic approach to
improve cognition, learning, andmemory in fragile X, there needs
to be a restoration of stimulus-induced translation at synapses.
Is There an FMRP Connection to Arc Translation
Needed for mGluR-LTD?
A major goal in the plasticity field has been identifying the spe-
cific locally synthesized proteins necessary for distinct forms of
long-term synaptic plasticity. Onewell-studied genewith a revis-
ited link to FMRP is the activity-regulated cytoskeleton-associ-
ated protein, Arc/Arg3.1, an immediate-early gene that is in-
duced in response to numerous forms of activity, including
those that induce long-term potentiation (Steward and Worley,
2001). Following synaptic activation, the mRNA encoding Arc/
Arg3.1 is rapidly transported into dendrites and accumulates in
regions of activated synapses in an NMDA receptor-dependent
manner. Arc/Arg3.1 has also been shown to regulate AMPAR en-
docytosis through its interactions with dynamin and endophilin
2/3 (Castillo et al., 2008). Given that FMRP is known to associate
with ArcmRNA and that synaptosomes from Fmr1 KOmice have
excess Arc translation (Zalfa et al., 2003), one attractive model is
that FMRP-mediated translation of Arc mRNA in dendrites may
be necessary for the protein synthesis-dependent internalization
of AMPAR underlying mGluR-LTD (Ronesi and Huber, 2008).
However, Arc is neither known to be an LTD protein nor has it
been linked to mGluR-dependent forms of synaptic plasticity.
Two exciting recent papers provide new evidence to support
a model whereby Gp1 mGluRs stimulate the rapid translation
of Arc necessary for AMPAR internalization and LTD. Park
et al. (2008) show that mGluR-LTD is decreased albeit not
eliminated in Arc/Arg3.1 KO mice (Park et al., 2008). In cultured
hippocampal neurons from wild-type mice, the application of
DHPG normally results in a rapid (5 min) and protein synthesis-
dependent increase in Arc protein levels within the cell body
and proximal dendrites, which is consistent with amodel for local
translation (Park et al., 2008). In the accompanying paper,
Waung et al. (2008) provide three lines of evidence that bolster
an argument for local Arc mRNA synthesis, including data show-
ing that the local perfusion of DHPG onto severed dendrites
results in a protein synthesis-dependent increase in Arc protein
(Waung et al., 2008). Furthermore, acute blockade of new Arc
synthesis prevents the persistent internalization of AMPAR in
response to mGluR-LTD (Waung et al., 2008). The mechanism
of mGluR-induced Arc translation appears to involve in part the
general inhibition of local translation at the level of elongation
by activation of eukaryotic elongation factor-2 kinase (eEF2K)Neuron 60, October 23, 2008 ª2008 Elsevier Inc. 205
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favor the selective translation of Arc mRNA remains unclear.
The question becomes what is the role for FMRP in this model.
Park et al. (Park et al., 2008) found that the rapid mGluR-depen-
dent induction of Arc is absent in Fmr1 KO mice. These investi-
gators also observed that mGluR-LTD was protein synthesis
independent in Fmr1 KOmice, in keeping with a previous report,
although curiously they did not observe the exaggerated LTD
(Huber et al., 2002). Nonetheless, these data taken together
with previous work showing that Arc mRNA may be an FMRP
target suggest that elevated levels of Arc at synapses of
FMRP-deficient neurons (Zalfa et al., 2003) could lead to persis-
tent AMPAR internalization and altered LTD. Such a model can
now be tested. It would be interesting to examine whether any
defects in LTD or AMPAR trafficking in FMR1 KO mice could
be rescued by genetic reduction of Arc expression (i.e., hetero-
zygous mice). Further work is also needed to assess whether
Arc synthesis in dendrites is impaired in Fmr1 KO, for example,
by applying the indirect methods used by Waung et al. (2008)
to examine dendritic synthesis of Arc in wild-type neurons. It is
also important to determine that FMRP directly binds and re-
presses Arc mRNA translation in dendrites, which may be trans-
lated in excess in FMRP-deficient neurons.
While dysregulated Arc expression may be a major underlying
cause of the altered LTD and AMPAR trafficking defect in FXS,
there are other candidates to consider who may play equivalent
roles. It may not be a single protein whose dysregulation is re-
sponsible for the LTD/AMPAR phenotype. One candidate to
consider is MAP1b, whose rapid synthesis has been recently
linked to mGluR-LTD and AMPAR internalization (Davidkova
and Carroll, 2007). MAP1b expression was shown earlier to be
induced in hippocampal slices from WT, but not in Fmr1 KO,
where its expression was elevated at basal state (Hou et al.,
2006). Amyloid precursor protein, APP, is another FMRP-associ-
ated mRNA showing impaired DHPG-induced translation in
Figure 2. Visualization of Total and Phosphorylated
FMRP in Dendrites and Spines
Immunofluorescence and 3D reconstruction of a cultured
hippocampal neuron labeled for phosphorylated FMRP (red),
total FMRP (blue), and F-actin using phalloidin (green). Coloc-
alization of FMRP and phospho-FMRP within granules is
shown in white. FMRP is transiently dephosphorylated by
PP2A in response to mGluR activation to allow translation of
FMRP-bound mRNAs (Narayanan et al., 2007).
Fmr1 KO (Westmark and Malter, 2007). Soluble
forms of Ab are elevated in Fmr1 KO mice (West-
mark and Malter, 2007), and Ab is known to pro-
mote AMPAR internalization during LTD (Hsieh
et al., 2006). The FMRP target, PSD95 mRNA,
which is translationally dysregulated in Fmr1 KO
(Muddashetty et al., 2007) is believed to provide
a scaffold necessary for AMPAR trafficking and
LTD (Xu et al., 2008). Thus, future work is needed
to identify these and other locally synthesized
LTD proteins and assess their contribution to the
defects in mGluR-dependent plasticity in Fmr1 KO mice (Ronesi
and Huber, 2008).
Molecular Mechanism of FMRP-Mediated Repression
and Derepression
A key question has been how FMRP-mediated translational re-
pression is relieved or derepressed by activation of Gp1mGluRs.
Recent studies indicate that the phosphorylation status of
FMRP, controlled by a PP2a/S6K1 signaling module, provides
a dynamic mechanism to rapidly and bidirectionally regulate
mRNA translation in neurons (Narayanan et al., 2007, 2008).
Phosphorylated FMRP is known to associate with heavy (possi-
bly stalled) polyribosomes, whereas dephosphorylated FMRP is
run-off from heavy polysomes after azide treatment, suggesting
a possible role for phosphorylation in ribosome stalling (Ceman
et al., 2003). The primary phosphorylated FMRP residue, murine
Ser 499, is conserved across all species from Drosophila to hu-
mans (human Ser 500; Drosophila Ser 406). A phospho-specific
antibody to Ser 499 was used to demonstrate that themajority of
FMRP in dendritic granules exists in a phosphorylated form (Nar-
ayanan et al., 2007) (Figure 2). Protein phosphatase 2A (PP2A)
was identified as an FMRP phosphatase that can rapidly
(<30 s) dephosphorylate FMRP in response to Gp1 mGluR acti-
vation. FMRP apparently begins to be rephosphorylated at
2 min, with much higher levels of phosphorylated FMRP noted
at 10 min, although it is unclear whether it is the same FMRP
molecules that are de- and rephosphorylated (Figure 3). FMRP
rephosphorylation is known to partly involve mTOR-dependent
PP2A suppression. It is believed that the rapid dephosphoryla-
tion of FMRP allows mRNAs to be translated, whereas rephos-
phorylation represses translation. Consistent with this model,
total protein levels of PSD95 are modestly increased at 2 min
and significantly elevated at 10 min following DHPG treatment.
The PP2A inhibitor okadaic acid, but not other phosphatase
inhibitors, blocked the rapid DHPG-induced dephosphorylation206 Neuron 60, October 23, 2008 ª2008 Elsevier Inc.
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target mRNAs. Dendritic levels of phosphorylated FMRP are
markedly reduced following a 30 s treatment with DHPG; this
is blocked by okadaic acid. These data suggest that mGluR ac-
tivation of PP2A and FMRP dephosphorylation provides amech-
anism for rapid mRNA translation in dendrites, consistent with
a model wherein FMRP inhibition of ribosome stalling is tempo-
rarily relieved (Narayanan et al., 2007). A prediction from these
findings is that PP2A inhibition using okadaic acid may interfere
with mGluR-LTD.
In a subsequent report, ribosomal protein S6 kinase 1 (S6K1)
was identified as an FMRP kinase in vitro and in vivo (Narayanan
et al., 2008). S6K1 KO mouse hippocampal lysates show an
absence of FMRP phosphorylation and increased expression
of SAPAP3, mimicking the elevated expression of SAPAP3 in
Fmr1 KO and hinting at loss of FMRP-mediated translational re-
pression. These recent studies demonstrate that mGluR signals
can rapidly affect the levels of phosphorylated FMRP in den-
drites and suggest a model whereby translational responses at
synapses may be temporally controlled by the phosphorylation
status of FMRP downstream of mGluRs. An interesting corollary,
based on the identification of S6K1 as the major neuronal kinase
responsible for phosphorylating FMRP, is that the absence of
either the hamartin or tuberin proteins (TS1 and TS2, respec-
tively), responsible for another autistic spectrum disorder known
as tuberous sclerosis (TS), leads to constitutive activation of the
mTOR pathway and hyperphosphorylation of S6K1 (Yates,
2006). Thus, we could predict that FMRP would be hyperphos-
phorylated in TS, leading to the reduced or dysregulated transla-
Figure 3. Postsynaptic FMRP Signaling
Model
Following stimulation of Gp1 mGluRs (green), in-
active PP2A (gray) is immediately activated (green)
and dephosphorylates FMRP (orange), rapidly al-
lowing rapid translation of FMRP-associated
mRNAs. Within 5 min, mTOR (blue) is activated
via a homer cascade, inhibiting PP2A and activat-
ing S6K1 (red), leading to FMRP phosphorylation
and possible translational inhibition of FMRP tar-
get messages. Simultaneously, mTOR activates
translation in an FMRP-independent manner, trig-
gering a sustained maintenance of translation.
FMRP-dependent and -independent pathways
control AMPA receptor internalization and other
changes in synaptic function and spine morphol-
ogy that contribute to mGluR-LTD. Based on Nar-
ayanan et al., 2007, 2008, and references therein.
tion of FMRP mRNA targets. Two autism
spectrum disorders could thereby be
linked together in the postsynaptic
space, a cellular locale long believed to
be important in autism.
While the above studies are consistent
with a model whereby FMRP phosphory-
lation regulates translation at the level of
ribosome stalling (elongation), it is also
possible that FMRP regulation occurs
at the level of translational initiation,
whereby a translationally repressed mRNP becomes dere-
pressed. This would be consistent with FMRP being present in
both mRNPs (Zalfa et al., 2003) and polysomes (Feng et al.,
1997b) in brain. It is also conceivable that some mRNAs may be
regulated by FMRP at the level of ribosome stalling, whereas
others may be regulated at the level of initiation in mRNPs;
thus, no singlemechanismmayoccur exclusively.Onewell-stud-
ied model for translational derepression at synapses is the
cytoplasmic polyadenylation element binding protein, CPEB,
which binds to both a CPE in a-CaMKII mRNA and to maskin,
an mRNA-specific eIF4E binding protein (Huang et al., 2002).
When maskin is bound to CPEB, it is prevented from binding
eIF4G, which is necessary for translation initiation, and the
CPEB/maskin complex tethers the mRNA in a translationally
repressed mRNP complex. In response to NMDA receptor stim-
ulation, CPEB is phosphorylated, maskin affinity for CPEB is
decreased, and its interaction with eIF4G occurs, resulting in
polyadenylation and translation initiation (Huang et al., 2002).
An exciting recent study has discovered that CYFIP1, an FMRP
interacting protein (Schenck et al., 2001), has a noncanonical
eIF4E interacting domain, which forms a translationally dormant
mRNP complex with FMRP and associated mRNAs (Napoli
et al., 2008). In response to BDNF or DHPG stimulation, CYFIP1
is dissociated from eIF4E at synapses, allowing for translation.
Both translational repression and stimulus-inducedderepression
were dependent on the FMRP-CYFIP complex and their interac-
tionwithmRNAs. Thus, there are certain parallels with the CPEB-
Maskin mechanism, although it is unclear yet whether FMRP
phosphorylation status can regulate this mechanism. In thatNeuron 60, October 23, 2008 ª2008 Elsevier Inc. 207
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this may provide another means for translational regulation of
FMRP at synapses (Schenck et al., 2003).
FMRP as a Kinesin Adaptor for Regulated
Transport of mRNP Granules
While the vast majority of FMRP exists in polyribosomes (Khand-
jian et al., 2004; Stefani et al., 2004), FMRP is also present inmes-
senger ribonucleoprotein complexes (mRNP) (Zalfa et al., 2003),
and FMRP-mRNP complexes can associate with microtubules
(Wang et al., 2008a). Further, the interaction of FMRP-mRNPs
with microtubules is increased when mRNAs are released from
polyribosomes. These data suggest a model whereby the dy-
namic association of FMRPwith translationally repressed,micro-
tubule-associated mRNP complexes and polyribosomes might
be a mechanism linking mRNA transport in dendrites with
translational regulation at synapses (Wang et al., 2008a).
High-resolution fluorescence imaging studies in cultured neu-
rons have shown that FMRP traffics in the form of motile RNA
granules, which have been described for several localized
mRNAs and binding proteins (Kiebler and Bassell, 2006).
mRNA transport granules are believed to be translationally
repressedmRNP complexes. In that some granules contain ribo-
somes and some lack ribosomes, mRNAs can likely be re-
pressed at the level of initiation or elongation (Kiebler and Bas-
sell, 2006). Once localized to the appropriate sites, mRNAs are
believed to be released from granules and subsequently trans-
lated in response to appropriate physiological stimuli (Krichev-
sky and Kosik, 2001). FMRP is localized in granules in the
neurites of PC12 cells (De Diego Otero et al., 2002) and in the
dendrites (Antar et al., 2004, 2005) and axons (Antar et al.,
2006) of primary hippocampal neurons. In dendrites, FMRP
granules colocalize with ribosomal components and MAP1b
mRNA (Antar et al., 2005), a known FMRP ligand. Live-cell imag-
ing of EGFP-FMRP has revealed the active dendritic transport of
FMRP granules in amicrotubule-dependent manner (Antar et al.,
2005). In cultured hippocampal neurons, FMRP trafficking into
dendrites was stimulated by neuronal activity and activation of
Gp1 mGluRs (Antar et al., 2004); brief depolarization of neurons
using KCl resulted in a marked rise in FMRP levels in dendrites,
which was independent of protein synthesis. KCl-induced traf-
ficking was sharply attenuated byMPEP, anmGluR5 antagonist,
but not by antagonists of NMDA or AMPARs. The brief applica-
tion of DHPG, a Gp1 mGluR agonist, also increased FMRP
trafficking in dendrites, which was dependent on microtubules.
The importance of regulated FMRP trafficking is further under-
scored by observations in vivo of rapid and dynamic dendritic
FMRP localization in response to visual experience, and in this
example, trafficking was dependent on NMDA receptors (Gabel
et al., 2004). Taken together, these in vitro and in vivo studies
implicate distinct mechanisms for FMRP trafficking, which are
regulated by experience and activity and may contribute to
synaptic plasticity.
While in vitro studies show that FMRP is a component of
mRNA transport granules that traffic along microtubules in an
mGluR-dependent manner (Antar et al., 2005), we did not
know until recently whether FMRP was directly required for
this process. FMRP may instead be a passive passenger within208 Neuron 60, October 23, 2008 ª2008 Elsevier Inc.the RNA transport granule, which may control translation, but
have no influence on the active process of mRNA transport. To
assess whether FMRP might play a role in the regulation of
mRNA transport, a new study has used FISH and quantitative
digital imaging analysis to quantitatively analyze the levels of
dendritic mRNAs in response to DHPG in cultured hippocampal
neurons from WT and Fmr1 KO mice (Dictenberg et al., 2008).
Consistent with previous reports, there were no differences in
the localization of mRNAs at steady state for several FMRP-
associated mRNAs (i.e., MAP1b, a-CaMKII, SAPAP4, RGS-5,
and others). However, each of the mRNAs exhibited DHPG-
induced trafficking in WT neurons, which was either absent or
markedly attenuated in Fmr1 KO neurons. There was no
DHPG-induced trafficking of b-actin mRNA, which is known to
be bound by ZBP1 (Eom et al., 2003) and localized to dendrites
upon NMDA receptor activation (Tiruchinapalli et al., 2003).
These findings show that the localization of a subset of dendritic
mRNAs can be augmented upon mGluR activation and that
FMRP is a critical requirement for this regulated transport.
In Drosophila neurons, another recent report has demon-
strated a role for dFMRP in mRNA transport using live-cell imag-
ing of fluorescently tagged RNA reporter dynamics (Estes et al.,
2008). Of interest, mRNA granules in dFmr1 mutant neurons
were less motile and exhibited reduced directional movement,
suggesting that dFMRP may influence the quality and efficacy
of mRNA dynamics. These findings are quite complementary
to the study by Dictenberg et al. (2008) and provide a striking ex-
ample of how an evolutionarily divergent protein has conserved
a critical developmental function, and both reports represent
a major breakthrough in our understanding of the mechanism
of mRNA transport and molecular defects contributing to FXS.
The study by Dictenberg et al. (2008) provides new insight into
the molecular mechanism. FMRP was shown to facilitate mRNA
transport in response to DHPG by acting as an adaptor for kine-
sin-1, via an interaction between the C terminus of FMRP that
contains the RGG box and kinesin light chain (Dictenberg
et al., 2008), the known cargo-binding subunit. Dominant-nega-
tive constructs to either KLC or FMRP impaired the DHPG-in-
duced localization of mRNAs to dendrites. Importantly, live-cell
imaging of a-CaMKII 30UTR, visualized by the MS2-GFP tagging
method, demonstrated sharply reduced RNA granule motility in
DHPG-stimulated neurons from Fmr1 KO mice. In addition, sev-
eral FMRP-ligand mRNAs (i.e., MAP1b, a-CaMKII, SAPAP4, and
RGS5) showed reduced kinesin interaction in vivo in Fmr1 KO
mice. Since mRNA localization was not impaired at basal levels,
these data suggest the presence of other as yet unidentified
mRNA-binding proteins, which may play a role in the constitutive
localization or maintenance of these mRNAs in dendrites.
It remains unclear whether FMRP directly binds to KLC. Inter-
actions between FMRP with kinesin heavy chain (Kif5b) have
been reported in mice and Drosophila (Kanai et al., 2004; Ling
et al., 2004); however, the preparations used could not rule out
the possibility that kinesin light chain was present. It is also pos-
sible that FMRPmay be an adaptor for multiple motors. An inter-
action between FMRP and Kif3C was observed via biochemical
and ultrastructural methods (Davidovic et al., 2007), and a dom-
inant-negative construct to Kif3C reduced the density of FMRP
granules in distal dendrites. However, this study did not address
Neuron
Reviewwhether an interaction between FMRP and Kif3C was involved in
mRNA localization.
Microtubules infrequently enter the dendritic spine, which is an
actin-rich compartment. This raises the attractive idea that
mRNA localization into the spine may involve amyosin motor. In-
terestingly, myosin Va was shown to facilitate the localization of
TLS, an mRNA binding protein, and its ligand mRNA into spines
following activation of Gp1 mGluRs (Yoshimura et al., 2006). Fu-
ture work may reveal similar FMRP-myosin interactions involved
in mRNA delivery into spines.
More studies are needed to identify themolecular composition
of FMRP-associated RNA transport granules. To date, there
have been proteomics studies to analyze the composition of
RNA granules purified using various methods (Kiebler and Bas-
sell, 2006). These studies have revealed that RNA granules are
quite heterogeneous in size and composition. We now recognize
that, in addition to RNA transport granules, there are P bodies
and stress granules that are also present in neuronal processes
and may play roles in mRNA degradation and translational re-
pression. The possibility that mRNAs shuttle between different
forms of RNA granules and polysomes to influence mRNA regu-
lation is a newly appreciated idea (Kiebler and Bassell, 2006).
RNA granules can disassemble in response to neuronal activity,
releasing component mRNAs into polysomes (Krichevsky and
Kosik, 2001). With regard to FMRP, it is known to interact with
P body components in Drosophila (Barbee et al., 2006) and
also stress granules in cultured mammalian cells (Mazroui
et al., 2002). FMRP has been hypothesized to act as a gate con-
trolling the release of mRNAs from granules into polysomes (As-
chrafi et al., 2005); the potential molecular mechanism behind
this, however, is unknown. It will be a challenge to characterize
the protein and RNA composition of distinct FMRP-associated
granules and assess their function in mRNA transport, stability,
and translational regulation in dendrites and synapses.
The Role of FMRP in Axonal Development
and Presynaptic Function
An exciting recent study by Bureau and colleagues (Bureau et al.,
2008) revealed transient defects in ascending axonal projections
and their experience-dependent plasticity in barrel cortex during
a critical postnatal period of development from Fmr1 KO mice.
Laser-scanning photostimulation (LSPS) was used to focally un-
cage glutamate at different sites near presynaptic L4 neurons
within barrels. EPSPs were then recorded in single postsynaptic
L3 neurons to generate synaptic input maps. These ascending
L4 / L3 projections from barrels in Fmr1 KO mice showed
a 40% reduction in their average strength. Electrophysiological
analyses demonstrated that the reduction in the strength of the
axonal projections is due to reduced connection probability,
rather than a reduction in synaptic strength. Fmr1 KO mice
showed diffuse axonal arbors between L4 / L3 projections,
as analyzed using biocytin labeling of individual neurons and his-
tochemical visualization of arbors. In addition, Fmr1 KO mice
showed lack of experience-dependent plasticity following sen-
sory deprivation by whisker trimming. In another study, Hanson
and Madison (Hanson and Madison, 2007) developed an in vitro
system to assess synaptic connectivity in neuronal networks
mosaic for FMRP expression; they show that the presynapticneurons derived from Fmr1 KO have a lower connection proba-
bility than their WT counterparts. Analysis of FMRP in Drosophila
has also provided critical new insight into how the protein func-
tions in axon development and activity-dependent refinement of
synaptic connections (Tessier and Broadie, 2008). dFMRP is
a known requirement to limit axon growth and synapse formation
(Pan et al., 2004), andmore recently it was shown to facilitate ac-
tivity-dependent pruning of axon branches (Tessier and Broadie,
2008). Collectively, these findings from mice and fly models of
FXS represent major strides toward the characterization of axo-
nal and presynaptic defects.
Given the importance of axonal protein synthesis in axon guid-
ance and regeneration (Wang et al., 2007), it is necessary to as-
sess whether FMRP functions locally within axons to influence
guidance and synapse formation. In cultured neurons, FMRP is
localized to developing axons and growth cones, and growth
cones from Fmr1 KO mice have excess filopodia and impaired
dynamics (Antar et al., 2006). FMRP can be detected in regener-
ating axons in vivo and is associated with RISC components in
sciatic nerve preparation (Murashov et al., 2007). FMRP is colo-
calized with RISC components in axons and growth cones of
cultured DRG neurons (Hengst et al., 2006). It will important to
analyze whether FMRP may function downstream of receptors
for axon guidance factors to regulate local translation and
assess whether impairments in local translation, perhaps via
altered regulation of miRNAs, could account for the observed
axonal defects in FXS models. Although futsch (MAP1b) is one
dFMRP target whose translational impairment is already known
to account for the synaptic overgrowth phenotype in Drosophila
(Zhang et al., 2001), it is unclear whether this is caused by loss of
local translational regulation in axons.
A recent studybyPriceet al. (Price et al., 2007) reportsonavery
exciting and unexpected role for FMRP in nociceptive sensitiza-
tion and behaviors involved in pain processing, which may result
from the impaired regulation of local protein synthesis in axons. In
a battery of paradigms, Fmr1 KO mice display decreased noci-
ception due to dysregulated mGluR1/5 signaling involving both
ERK and mTOR regulation of protein synthesis. A particularly in-
teresting set of findings here suggests the presence of protein
synthesis in nociceptive axons that is important for pain process-
ing. Since the same investigators also showed that FMRP is local-
ized to nociceptive sensory axons (Price et al., 2006), these new
findings should open up a line of inquiry to identify FMRP targets
in axons whose local translation may be required for nociceptive
plasticity. Interest in pursuing this line of inquiry is intensified by
a recent study showing that local mGluR-regulated translation
in primary afferent fibers regulates nociception (Jimenez-Diaz
et al., 2008). Further studiesmayprovide important links between
altered nociceptive sensitization in Fmr1KOmice and the self-in-
jurious behavior reported in some fragile X syndrome patients.
Importantly, these studies further define the breadth of FMRP
functions and the role of local protein synthesis regulation
throughout the central and peripheral nervous system.
The Role of FMRP in the Regulation of GABA(A)
Receptor Subunits
GABA(A) receptors provide the major form of inhibitory synaptic
transmission in the brain; they are important for the synapticNeuron 60, October 23, 2008 ª2008 Elsevier Inc. 209
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FMRP is in a complex with several translationally arrested mRNAs at the synapse. Following mGluR stimulation, FMRP-target mRNAs are rapidly derepressed,
allowing for local translation. A second phase of FMRP-dependent plasticity is shown that involves the subsequent transport of new mRNAs from the cell body
into dendrites. The model shown here illustrates translational repression at the level of elongation, as suggested by Ceman et al. (2003). The translational acti-
vation and repression of mRNA is regulated by a PP2A/S6K1 signaling module (Narayanan et al., 2007, 2008) (see Figure 3). (1) Upon mGluR1/5 activation, PP2A
is rapidly activated and dephosphorylates FMRP, thereby allowing for (2) local translation of proteins that affect AMPAR trafficking, i.e., PSD-95, Arc, Map1b, and
App (Westmark andMalter, 2007; Todd et al., 2003;Muddashetty et al., 2007; Hou et al., 2006; Davidkova andCarroll, 2007;Waung et al., 2008; Park et al., 2008).
Following mGluR activation, FMRP is rephosphorylated by S6K1 with slower kinetics, leading to translational repression. (3) FMRP can also be ubiquitinated
following mGluR stimulation, and its proteosome-dependent degradation is necessary for mGluR-LTD (Hou et al., 2006). The local degradation of FMRP may
contribute to local protein synthesis underlying mGluR-LTD. A mechanism of local FMRP degradation may be balanced by its synthesis. FMRP is synthesized
in synaptoneurosomes upon mGluR activation (Weiler et al., 1997), which may provide a feedback mechanism to restore translational repression. Upon mGluR
stimulation, (4) there may be a retrograde signal that leads to the transport of new FMRP-associated mRNAs from the soma. The active bidirectional transport of
FMRP granules in dendrites has recently been described (Dictenberg et al., 2008). This model speculates that FMRP itself may traffic from the synapse to the cell
body and/or nucleus, where it may complex with new target mRNAs, and return to the activated synapse. (5) In that FMRP can shuttle into the nucleus (Eberhart
et al., 1996), it will be interesting to assess whether nucleocytoplasmic trafficking is regulated by mGluR signaling. (6) FMRP has recently been shown to be nec-
essary for the transport of several mRNAs into dendrites, whereas neurons cultured from Fmr1 KO mice show impaired mRNA transport dynamics (Dictenberg
et al., 2008). This model speculates that the trafficking population of FMRP is phosphorylated; however, future work is needed to assess whether FMRP phos-
phorylation may influence mRNA trafficking.plasticity associated with learning and memory, and they are af-
fected in disease states, such as epilepsy and anxiety. GABA(A)
receptors are present along proximal dendrites of glutamatergic
neurons, often noted near the spine neck, thus allowing for the
inhibitory regulation of glutamatergic signaling. Several subunits
of GABA(A) are reduced in the brains of Fmr1 KO mice, most
notably the delta subunit (D’Hulst et al., 2006). Interestingly, in
another study the mRNA for the delta subunit was shown to be
an FMRP ligand, also altered in its expression in dendrites (Miya-
shiro et al., 2003). Most recently, the mRNA encoding GABA(A)
receptor delta subunit was shown to be dendritically localized
in response to mGluR activation inWT, but not Fmr1 KO neurons
(Dictenberg et al., 2008). This unexpected finding reveals a
surprising coordinate regulation between mGluRs and GABA(A)
receptors and suggests a possible homeostatic mechanism that
may be altered in FXS. In view of the above evidence of links
between FMRP and GABA(A) receptor subunit expression and
localization, it will come as no surprise that recent reports have
revealed impairments in GABA synaptic transmission (Centonze
et al., 2008; Curia et al., 2008). In the Drosophila model of FXS,
a chemical library screen identified three compounds implicated
in GABAergic signaling, including GABA itself, which rescued
several mutant phenotypes (Chang et al., 2008). We envision
future research yielding fresh insight into the mechanisms
whereby FMRP-mediated translation is involved in GABAergic
synaptic transmission as well as the role of FMRP at the interface
between excitatory and inhibitory signaling pathways regulating
translation.
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Collectively, recent studies on FMR1 phenotypes in mouse and
fly models of FXS provide strong evidence of diverse roles for
FMRP in the regulation of neuronal development and plasticity,
in both the central and peripheral nervous system. As discussed
above, FMRP not only plays important roles in the adult synaptic
plasticity underlying learning and memory, but also appears to
be involved in axonal development, synapse formation, and
the development and wiring of neuronal circuits (see also Gibson
et al., 2008). FMRP appears to act similarly in many settings to
control or limit morphologic changes in both axons and dendrites
that are involved in synapse development and plasticity. There
may therefore be more similarities in the mechanisms underlying
dendritic, axonal, and synaptic impairments in FMR1 KO than
previously thought. Importantly, recent evidence suggests that
FMRP may regulate local protein synthesis in axons, as well as
dendrites.
Future studies are likely to take several different directions.
Rigorous characterization of the molecular mechanism behind
the FMRP-mediated regulation of mRNA transport and local
translation is essential (see proposed model in Figure 4). One
major avenue to explore is FMRP’s interaction with dendritic
miRNAs (Kye et al., 2007), which have recently been shown to
regulate dendritic protein synthesis important for dendritic spine
development (Schratt et al., 2006). Recent analysis indicates
dysregulation of several miRNAs across the autism spectrum
(Abu-Elneel et al., 2008), and thus it is critical to identify and as-
sess how FMRP interactions with specific dendritic miRNAsmay
be dysregulated. Research is needed to characterize the precise
mechanism whereby FMRP phosphorylation regulates transla-
tion, at the level of elongation and/or initiation, and the role of
noncoding mRNAs and specific FMRP mRNA binding domains.
It will be interesting to determine whether phosphorylation of
FMRP and translational regulation occurs downstream of other
receptors besides mGluRs. Recent evidence implicates altered
signaling through Gq-coupled, M1 muscarinic acetylcholine re-
ceptors (mAChRs) in Fmr1 KO (Volk et al., 2007). In addition to
the discussed studies reporting altered GABA receptor-medi-
ated synaptic transmission, there is also recent evidence of al-
tered dopamine receptor signaling in Fmr1 KO (Wang et al.,
2008b; Weinshenker and Warren, 2008). Future studies may
position FMRP-mediated translation downstream of GABA and
dopamine receptors, and maybe even receptors for neurotro-
phins and axon guidance factors.
One critical goal for future work will be the attempt to match
the specific mRNA ligands with specific FX phenotypes. For
example, a number of FMRP ligands encode proteins important
for the regulation of AMPAR trafficking, such as Arc, MAP1b,
PSD-95, and APP (Ronesi and Huber, 2008) (see also Figure 4).
We need to know whether any of these proteins are elevated at
synapses of FMRP-deficient neurons, as suggested by Zalfa
et al. (2003), and contribute to the excess internalization of
AMPAR (Nakamoto et al., 2007). Further analysis of these and
other critical FMRP ligands responsible for certain FX pheno-
types, as well as the detailed molecular mechanisms involved
in translational regulation, will pave the way to new therapies,
which can perhaps be used in concert with drugs that act on
Gp1 mGluRs. FX research has held out as a model of transla-tional neuroscience, whereby the recent insights into FMRP
function and strategies for the correction of phenotypes in FX
model organisms offer hope for treating other autism spectrum
disorders that affect learning and behavior.
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